How does COVID-19 impact psoriasis practice, prescription patterns, and healthcare delivery for psoriasis patients? A cross-sectional survey study.

Mohamed Hussein Medhat El-Komy Asmaa Abdelnaby Mona El-Kalioby

Published in: Journal of cosmetic dermatology (2021)

The COVID-19 pandemic has a negative impact on psoriasis management and healthcare delivery. Dermatologists are cautious about using biologics and immunosuppressive drugs during the pandemic, making case-by-case decisions. Psoriasis patients need compliance monitoring, and psychological support during the pandemic, which can be facilitated by teledermatology.

Keyphrases

healthcare
coronavirus disease
end stage renal disease
sars cov
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
primary care
atopic dermatitis
depressive symptoms
social media
quality improvement
drug induced
health information